Myeloid sarcoma of the small intestine in a patient without overt acute myeloid leukaemia: a challenging diagnosis of a rare condition

BMJ Case Reports
Rodrigo Athayde NemésioJúlio Soares Leite

Abstract

Myeloid sarcoma (MS) is a rare condition that most commonly occurs in the setting of acute myeloidleukaemia (AML) or other chronic myeloproliferative disorders. It presents as an abnormal growth that can develop anywhere in the human body, and its clinical manifestations are often non-specific.We present the case of a patient admitted to the emergency room with bowel obstruction. After careful clinical assessment, she underwent a right hemicolectomy. After a thorough examination of the surgical pathology specimen, including testing a wide array of immunohistochemical markers, the patient was timely diagnosed with MS, allowing for the implementation of the appropriate treatment to achieve complete remission. This is crucial, since non-leukaemic patients with untreated MS always progress to AML, and have a better prognosis if adequate therapy is implemented early. Our patient is now in the second postoperative year and shows no signs of relapse.

References

Sep 1, 1995·Annals of Internal Medicine·K R ImrieA Keating
Aug 1, 1997·Journal of the American Academy of Dermatology·M J SisackN Sidhu-Malik
Aug 31, 2006·The British Journal of Radiology·H NishidaT O'Uchi
Nov 2, 2007·Diagnostic Pathology·Borislav A AlexievXianfeng F Zhao
Jul 22, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Osama QubaiahGraça M Dores
Jun 3, 2011·World Journal of Gastroenterology : WJG·Lola Y KwanDavid Q Shih
Dec 12, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Darko AnticDragica Tomin
Aug 12, 2014·International Journal of Surgery Case Reports·Carlo M GirelliGiovanni Serio
Sep 2, 2014·Journal of Clinical and Diagnostic Research : JCDR·Smeeta GajendraPranay Tanwar
Dec 17, 2017·Medicine·Simona GurzuIoan Jung

❮ Previous
Next ❯

Citations

Nov 11, 2019·Abdominal Radiology·Abdelrahman K HanafyKhaled M Elsayes

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.